StonvexLoading…
StonvexStonvexStonvexCore line items from DNOW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.82B | $2.37B | $2.32B | $2.14B |
Operating Income | $-93.00M | $109.00M | $144.00M | $131.00M |
Net Income | $-89.00M | $78.00M | $250.00M | $128.00M |
EPS (Diluted) | $-0.76 | $0.71 | $2.27 | $1.13 |
Total Assets | $3.92B | $1.62B | $1.53B | $1.32B |
Total Liabilities | $1.69B | $493.00M | $466.00M | $476.00M |
Cash & Equivalents | $164.00M | $256.00M | $299.00M | $212.00M |
Free Cash Flow OCF − CapEx | $134.00M | $289.00M | $171.00M | $-9.00M |
Shares Outstanding | 186.13M | 105.65M | 106.26M | 110.37M |